Duchenne muscular dystrophy: Management of difficult airway and concurrent bronchospasm

Sergey Pisklakov, Jason Chiu, Vanny Le, Anuradha Patel, Vasanti Tilak

Research output: Contribution to journalArticlepeer-review


Using succinylcholine and inhalation agents for patients with Duchenne muscular dystrophy is extremely risky. Those risks include heart failure, cardiac dysrhythmias, rhabdomyolysis and malignant hyperthermia. Even in emergent situations, such as intraoperative bronchospasm, succinylcholine and inhalational agents are often considered contraindicated. Nevertheless, if intraoperative bronchospasm does occur in a patient with Duchenne muscular dystrophy, the benefits of using inhalational agents to treat bronchospasm may outweigh the risks in certain situations.

Original languageEnglish (US)
JournalJournal of Anesthesia and Clinical Research
Issue number11
StatePublished - Nov 2012
Externally publishedYes


  • Bronchospasm
  • Difficult airway management
  • Duchenne muscular dystrophy
  • Rhabdomyolysis
  • Volatile anesthetics

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine


Dive into the research topics of 'Duchenne muscular dystrophy: Management of difficult airway and concurrent bronchospasm'. Together they form a unique fingerprint.

Cite this